Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Richard Chappell
University of Wisconsin Madison, Department: Public Health & Prev Medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Keryx Pharmaceuticals, Inc.
Payment for services (e.g., consulting fees, honoraria, paid authorship)
We were informed that the Investigator, Richard Chappell, no longer works or has association with Keryx Pharmaceuticals, and has not since 2014. This reported potential FCOI is no longer applicable, and it should be withdrawn.
Genotype-gUIded vitamin D supplEmentation (GUIDE)
The rationale for the proposed research is that the current vitamin D recommendations and clinical trials take a 'one size fits all' approach, but responses to vitamin D supplementation do not follow this pattern. Applying a pharmacogenomic approach to vitamin D supplementation could be extremely beneficial. Since pharmacogenomic panels are being developed and used in clinical laboratories to aid in clinical decision- making, this is an opportune time to consider the efficacy of genotype-guided vitamin D supplementation.
Filed on January 26, 2016.
Tell us what you know about Richard Chappell's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Richard Chappell”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Richard Chappell | University of Wisconsin Madison | Conflict of Interest | Abbvie Pharmaceuticals | $150,000 - $199,999 |
| Richard Chappell | University of Wisconsin Madison | Conflict of Interest | Abbvie Pharmaceuticals | $150,000 - $199,999 |
| Richard Chappell | University of Wisconsin Madison | Conflict of Interest | Takeda | $5,000 - $9,999 |
| Richard Chappell | University of Wisconsin Madison | Conflict of Interest | Abbvie Pharmaceuticals | $150,000 - $199,999 |
| Richard Chappell | University of Wisconsin Madison | Conflict of Interest | Takeda | $5,000 - $9,999 |
| Richard Chappell | University of Wisconsin Madison | Conflict of Interest | Abbvie Pharmaceuticals | $5,000 - $9,999 |
| Richard Chappell | University of Wisconsin Madison | Conflict of Interest | Takeda | $5,000 - $9,999 |
| Richard Chappell | University of Wisconsin Madison | Conflict of Interest | Kraft Foods, Inc. | $10,000 - $19,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.